Semaglutide Tablets(Hangzhou Nuoao Biomedical)

司美格鲁肽片（杭州诺澳生物）

Report date: 2026/02/11 20:01:36

Base Information

Drug NameSemaglutide Tablets(Hangzhou Nuoao Biomedical)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Nuoao Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Nuoao Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A